Physician profile
Kathy T Tran
NPI 1346355401
$5,911.48
in general payments reported to CMS, 2019-2025
14 companies · $762 in 2025
The $762 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $66.58 · 2021: $794 · 2022: $921 · 2023: $1,097 · 2024: $1,296 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455 · Consulting Fee: $1,125 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.77 |
| Consulting Fee | $1,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,085.08 | 2019-2025 | Air Optix |
| Coopervision INC. | $1,231.95 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $977.68 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $481.78 | 2023-2024 | Miebo, Infuse |
| Lumenis Be INC | $465.59 | 2024 | Optilight |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $174.11 | 2019-2021 | |
| Allergan, INC. | $124.55 | 2019 | |
| Glaukos Corporation | $123.76 | 2023-2024 | Kxl System (Not Refurbished), Ce-Marked Kxla System |
| Johnson & Johnson Surgical Vision, INC. | $109.38 | 2019-2022 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $31.81 | 2025 | |
| Carl Zeiss Meditec, INC. | $27.20 | 2023 | Clarus, Cirrus Hd-Oct, Humphrey Field Analyzer (Hfa3) |
| Sight Sciences, INC. | $22.68 | 2023 | Tearcare System |
| Abbvie INC. | $17.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.